We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




PCR-Based Diagnostics Move Out of the Lab and into the Field

By LabMedica International staff writers
Posted on 10 Sep 2014
Researchers in New Zealand have revealed a novel battery-powered, handheld quantitative PCR analyzer for use under field conditions to detect minute levels of viral or bacterial DNA.

Investigators at the University of Otago (New Zealand) recently described a robust unit weighing about the same as a typical laptop computer and able to fit on the palm of the hand. More...
The so-called "Freedom4" instrument boasts a six-hour battery life and can be attached by cable to a laptop computer, or connected wirelessly to a smart phone or tablet computer that is running a custom software application able to analyze and interpret the test results.

“We are immensely proud that we have created this brilliant device; there is currently no other system in the world that compares in terms of the analytical power we have achieved at this level of mobility and ease of use, said Dr. Jo-Ann Stanton, senior research fellow in the department of anatomy at the University of Otago. “This mobility could provide a great boon for farmers. For instance, vets could drive around a farm analyzing samples from various locations, make their diagnoses and treat infected animals—all in one trip.”

A prototype Freedom4 instrument was evaluated by the New Zealand Institute of Environmental and Scientific Research (Wellington). Results obtained by assays for toxin-producing E. coli, and several gastrointestinal and respiratory viruses—including the H1N1 serotype influenza virus—were said to correlate well with those from much larger laboratory-based DNA analysis systems.

Related Links:
University of Otago
New Zealand Institute of Environmental and Scientific Research



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.